Very low levels of remdesivir resistance in SARS-COV-2 genomes after 18 months of massive usage during the COVID19 pandemic: A GISAID exploratory analysis-Reference-Cited by-同舟云学术

Very low levels of remdesivir resistance in SARS-COV-2 genomes after 18 months of massive usage during the COVID19 pandemic: A GISAID exploratory analysis

Published:2022-02 Issue: Volume:198 Page:105247
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Focosi Daniele^ORCID,Maggi Fabrizio,McConnell Scott,Casadevall Arturo

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference46 articles.

1. Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease;Agostini;mBio,2018

2. Evolution of viral variants in remdesivir-treated and untreated SARS-CoV-2-infected pediatrics patients;Boshier;J. Med. Virol.,2021

3. Machine learning identifies molecular regulators and therapeutics for targeting SARS-CoV2-induced cytokine release;Chan;Mol. Syst. Biol.,2021

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2 Genotyping Highlights the Challenges in Spike Protein Drift Independent of Other Essential Proteins;Microorganisms;2024-09-09

2. Oral pharmacokinetics and efficacy of oral phospholipid remdesivir nucleoside prodrugs against SARS-CoV-2 in mice;Antimicrobial Agents and Chemotherapy;2024-09-06

3. Structural and virologic mechanism of the emergence of resistance to M ^pro inhibitors in SARS-CoV-2;Proceedings of the National Academy of Sciences;2024-09-05

4. Design, synthesis, and biological activity evaluation of dihydromyricetin derivatives against SARS-CoV-2-Omicron virus;Journal of Enzyme Inhibition and Medicinal Chemistry;2024-08-29

5. Comprehensive Review of COVID-19: Epidemiology, Pathogenesis, Advancement in Diagnostic and Detection Techniques, and Post-Pandemic Treatment Strategies;International Journal of Molecular Sciences;2024-07-26